Wisconsin Bio News

Read the full press release here Advocate Aurora Health recently joined a clinical trial evaluating the role of a presurgical screening and care model, or toolkit, in improving surgical care and outcomes in older patients with cancer. The study, “Use of a pre-surgical toolkit in improving surgical care and outcomes in older participants with cancer,” […]

Read the full press release here Aurora St. Luke’s Medical Center in Milwaukee is the first site in Wisconsin participating in a post-market clinical trial evaluating a device designed to reduce the risk of stroke after a noninvasive heart valve replacement procedure. The trial, “PROTECTED TAVR: Stroke protection with Sentinel during transcatheter aortic valve replacement,” […]

Read the full press release here Janesville-based nuclear technology company SHINE Medical Technologies said Wednesday it has begun selling a therapeutic isotope it produces that’s used to treat cancers. SHINE recently announced it made its first commercial sales of lutetium-177, or Lu-177, to multiple customers. In addition to neuroendocrine cancers, the isotope can be used […]

Read the full press release  In a recent prospective, blinded study, the novel Versiti PF4-dependent P-selectin expression assay (PEA) was found to be highly accurate for the diagnosis of heparin-induced thrombocytopenia (HIT), a life-threatening, pro-thrombotic, antibody-mediated disorder that can cause blood clots, resulting in heart attacks, strokes and limb amputation. Further results of the study, […]